The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline

Biological Psychiatry

Volumn 42, Issue 10, 1997, Pages 925-931

  Ng Ying Kin, N M K ^a,b   Vasavan Nair, N P ^a,b   Amin, Mohammed ^a,b   Schwartz, George ^a,b   Ahmed, S Kamalludin ^a   Holm, Per ^e   Katona, Cornelius ^c   Kragh Sorensen, Per ^d   Klitgaard, Niels ^d   Song, Wei Yi ^a   West, Thomas E G ^a   Stage, Kurt ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e Dept of Intl Clinical Research ^*  (Denmark)

Author keywords

Dexamethasone suppression test; Geriatric depression; Moclobemide; Nortriptyline; Placebo

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; MOCLOBEMIDE; NORTRIPTYLINE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; HAMILTON SCALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZAMIDES; DEPRESSIVE DISORDER; DEXAMETHASONE; DOUBLE-BLIND METHOD; HUMANS; HYDROCORTISONE; MOCLOBEMIDE; NORTRIPTYLINE; SEVERITY OF ILLNESS INDEX;

EID: 9844263383     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00158-3     Document Type: Article

References (36)

1. Alevizos B, Hatzimanolis J, Markianos M, Stefanis CN (1993): Clinical, endocrine and neurochemical effects of moclobemide in depressed patients. Acta Psychiatr Scand 87:285-290.
2. The APA Task Force on Laboratory Tests in Psychiatry (1987): The dexamethasone suppression test: An overview of its current status in psychiatry. Am J Psychiatry 144:1253-1262.
3. Arana GW, Workman PJ, Baldessarini RJ (1984): Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. Am J Psychiatry 141:1619-1620.
4. Axelson DA, Doraiswamy PM, McDonald WM, Boyko OB, Tupler LA, Patterson LJ, et al (1993): Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 47:163-173.
5. Barden N (1992): Antidepressant regulation of glucocorticoid receptor gene expression. Clin Neuropharmacol 15(suppl 1):586A-587A.
6. Carroll BJ, Curtis GC, Mendels J (1976): Neuroendocrine regulation in depression: II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 33:1051-1058.
7. Carroll BJ (1980a): Clinical application of neuroendocrine research in depression. In: van Praag MH, Lader MH, Rafaelsen OJ, Sachar EJ, editors. Handbook of Biological Psychiatry, Part III. Brain Mechanisms and Abnormal Behavior - Genetics and Neuroendocrinology. New York: Marcel Dekker, pp 179-193.
8. Carroll BJ, Schroeder K, Mukhopadhyay S, Greden JF, Feinberg M, Ritchie J, et al (1980b): Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression. J Clin Endocrinol Metab 51:433-437.
9. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, et al (1981): A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15-22.
10. Carson SW, Halbreich U, Yeh CM, Asnis G, Goldstein S (1988): Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects. Biol Psychiatry 24:569-577.
11. Coryell W, Zimmerman M (1987): HPA-axis abnormalities in psychiatrically well controls. Psychiatry Res 20:265-273.
12. Evans DL, Nemeroff CB (1987): The clinical use of the dexamethasone suppression test in DSM-III affective disorders: Correlation with the severe depressive subtypes of melancholia and psychosis. J Psychiatric Res 21:185-194.
13. Feinberg M, Carroll BJ (1984): Biological "markers" for endogenous depression: Effects of age, severity of illness, weight loss and polarity. Arch Gen Psychiatry 41:1080-1085.
14. Gastpar M, Gilsdorf U, Abou-Saleh MT, Ngo-Khac T (1992): Clinical correlates of response to DST. The dexamethasone suppression test in depression: A World Health Organization collaborative study. J Affect Disord 26:17-24.
15. Guthrie SK, Vartanian L, Grunhaus L, Hariharan M, Pande A, Haskett RF (1990): A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs. Acta Psychiatr Scand 82:427-432.
16. Holsboer F, Haack D, Gerken A, Vecoei P (1984): Plasma dexamethasone concentrations and different suppression response of cortisol and corticosterone in depressives and controls. Biol Psychiatry 19:281-291.
17. Hunt GE, Johnson GFS, Caterson ID (1989): The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls. J Affect Disord 17:21-32.
18. Johnson GF, Hunt G, Kerr K, Caterson I (1987): The plasma dexamethasone "window" and the dexamethasone suppression test in depression. Biol Psychiatry 22:1033-1035.
19. Kream J, Mulay S, Fukushima DK, Solomon S (1983): Determination of plasma dexamethasone in the mother and the newborn after administration of the hormone in a clinical trial. J Clin Endocrinol Metab 56:127-133.
20. Maes M, Vandewoude M, Schotte C, Maes L, Martin M, Blockx P (1990a): A revised interpretation of postdexamethasone ACTH and cortisol findings in unipolar depressed females. Psychiatry Res 34:107-126.
21. Maes M, Minner B, Suy E (1990b): Prediction of the DST results in depression by means of free urinary cortisol, availability of dexamethasone, age and diagnostic classification. Biol Psychiatry 28:349-357.
22. Maguire KP, Schweitzer NB, Bridge S, Tiller JWG (1987): The dexamethasone suppression test: Importance of dexamethasone concentrations. Biol Psychiatry 22:957-967.
23. Nair NPV, Amin M, Holm P, Katona C, Kiltgaard N, Ng Ying Kin NMK, et al (1995): Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo. J Affect Disord 33:1-9.
24. O'Sullivan BT, Hunt GE, Johnson GF, Caterson ID (1989): The plasma dexamethasone window: Evidence supporting its usefulness to validate dexamethasone suppression test results. Biol Psychiatry 25:739-754.
25. Poland RE, Rubin RT, Lane LA, Hart PJ, Lesser IM (1987): Serum dexamethasone concentration and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response. Arch Gen Psychiatry 44:790-795.
26. Poland RE, Rubin RT, Lesser IM (1988): Serum dexamethasone concentrations in endogenous depressives before, during and after treatment: Preliminary observations. Biol Psychiatry 23:705-710.
27. Ravindran AV, Bialik RJ, Lapierre YD (1994): Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test. J Affect Disord 31:111-117.
28. Ribeiro SC, Tandon R, Grunhaus L, Greden JF (1993): The DST as a predictor of outcome in depression: A meta-analysis. Am J Psychiatry 150:1618-1629.
29. Ritchie JC, Belkin BM, Krishnan RR, Nemeroff CB, Carroll BJ (1990): Plasma dexamethasone concentrations and the dexamethasone suppression test. Biol Psychiatry 27:159-173.
30. Rubin RT, Poland RE, Blodgett ALN, Winston RA, Forster B, Carroll BJ (1980): Cortisol dynamics and dexamethasone pharmacokinetics in primary ED: Preliminary findings. In: Brambilla F, Racagni G, deWeid D, editors. Progress in Psychoneuroendocrinology Amsterdam: Elsevier/North Holland, pp 223-234.
31. Sachar EJ, Puig-Antich J, Ryan ND, Asnis GM, Rabinovich H, Davies M, et al (1985): Three tests of cortisol secretion in adult endogenous depressives. Acta Psychiatr Scand 71:1-8.
32. Seckl JR, Fink G (1992): Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 55:621-626.
33. Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, et al (1984): Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. Arch Gen Psychiatry 41:257-267.
34. Traskman L, Tybring G, Asberg M, Bertilsson L, Lautto O, Schalling D (1980): Cortisol in the CSF of depressed and suicidal patients. Arch Gen Psychiatry 37:761-767.
35. Whiteford HA, Peabody CA, Csernansky JG, Warner MD, Berger PA (1987): Elevated baseline and postdexamethasone cortisol levels: A reflexion of severity of endogenicity? J Affect Disord 12:199-202.
36. Young RC, Alexopoulos GS, Manley MW, Shamoian CA, Dhar AK, Kutt H (1984): Treatment outcome in elderly depressives: Plasma nortriptyline concentration and pretreatment dexamethasone suppression test. In: Usdin E, Asberg M, Bertilsson L, Sjoquist F, editors. Frontiers in Biochemical and Pharmacological Research in Depression. New York: Raven Press, pp 207-211.